MedTrace Logo

Influence of Perioperative Fluid Therapy on Hemoglobin and Methemoglobin Levels

NCT03220620 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2020-11-03

No results posted yet for this study

Summary

The objective of the study is to evaluate influence of perioperative fluid therapy on Methemoglobin levels, and to changes in hemoglobin. Further, changes in Methemoglobin will be related to metabolic signs of oxidative stress (changes in blood lactate). Patients undergoing major abdominal surgery will be included into the study.

Conditions

  • Perioperative/Postoperative Complications
  • Fluid Overload
  • Hemoglobin H

Interventions

OTHER

GDT

individualized fluid therapy

Sponsors & Collaborators

  • University of Rostock

    lead OTHER

Principal Investigators

  • Thomas Mencke, Prof. · University of Rostock

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-14
Primary Completion
2019-12-31
Completion
2020-01-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03220620 on ClinicalTrials.gov